Quantcast

Latest Antibody Stories

2015-01-22 23:07:03

Selexis SA Is the First Biotechnology Company to Deliver Manufacturing-Ready Research Cell Banks with a Fully Sequenced Genome and Transcriptome Geneva, Switzerland

2015-01-16 23:03:36

Researchmoz.us announces new research report on Antibody Partnering Terms and Agreements to it's huge collection.

2015-01-14 08:28:46

OXFORD, England, January 14, 2015 /PRNewswire/ -- Oxford BioTherapeutics announces today that Boehringer Ingelheim has exercised an option to receive exclusive rights to

2015-01-08 23:07:31

Today, MBS is announcing the release of three monoclonal antibodies to chikungunya virus.

2015-01-08 23:06:47

Selexis SA announced today the first therapeutic biologic generated with the Selexis SUREtechnology Platform™ has been approved for market. Geneva, Switzerland

2015-01-05 23:04:40

Researchmoz announces new research report on Global and China Monoclonal Antibody Industry added to its huge database Albany, NY (PRWEB) January 05, 2015

2015-01-03 23:00:15

Researchmoz announces the new market research report on to its huge collection of research reports. Albany, NY (PRWEB) January 04, 2015 This market

2014-12-30 08:24:56

TEL AVIV, Israel, Dec. 30, 2014 /PRNewswire/ -- Tikcro Technologies Ltd.

2014-12-29 16:22:05

LONDON, Dec. 29, 2014 /PRNewswire/ -- REPORT HIGHLIGHTS The global market for antibody drugs was worth nearly $63.4 billion in 2013.


Word of the Day
postliminy
  • In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
  • In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.
The word 'postliminy' comes from a Latin word meaning 'threshold'.